Erschienen in:
07.08.2023 | Commentary
Drug Use and Human Milk: Legal and Child Welfare Considerations
verfasst von:
Anna Reed, Jaid Redmon-Greene, Heather Thompson, Indra Lusero
Erschienen in:
Maternal and Child Health Journal
|
Ausgabe 12/2023
Einloggen, um Zugang zu erhalten
Abstract
Introduction
Preventing new parents who use drugs from bonding with and bodyfeeding their babies undermines public health. Because U.S. culture treats substance use as a moral failing rather than a health concern, punitive responses to perinatal substance use continue to dominate. This is particularly true for families of color, who are more likely to be targeted by the family regulation system. These approaches fail to protect families, and cause their own, separate harm. This article will lay out existing evidence surrounding bodyfeeding. Then, it will debunk harmful mythologies about drug use and human milk, and compare the risks associated with using drugs while bodyfeeding to those inherent in family separation. Finally, it will make the case for harm-reduction approaches over criminal ones.
Objectives
The health risks associated with family separation are only rarely weighed against those associated with drug exposure through human milk. Our objective for this paper is to contribute new ways of framing the importance of keeping families together at birth, even when perinatal substance use is detected.
Methods
This manuscript is not based upon clinical study or patient data, and exclusively references studies and research publications that have been approved by the appropriate ethics committee and which have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Results
Significant research data support the position that the risks associated with family separation are arguably greater than those associated with exposure to substance use in human milk.
Conclusions for Practice
Harm reduction approaches should be favored over criminal approaches when perinatal substance use is detected or confirmed.